title: Distribution of ideal cardiovascular health in a community-based cohort of Middle East population.
abstract: OBJECTIVE
  To improve cardiovascular (CV) health of American population, the American Heart Association (AHA) developed definitions of ideal, intermediate, and poor CV health based on 7 accessible health metrics. The applicability of this construct and the distribution of its components in the community-based populations in the Middle East region have not been reported.
  
  
  METHODS
  A prospective population-based cohort study conducted from 1999 to 2011.
  
  
  METHODS
  We used data from phase 4 of Tehran Lipid and Glucose Study (2009-2011) (2861 women and 2004 men, aged >= 20 years) to estimate the frequency of CV health levels (ideal, intermediate, and poor) in adults of both genders, and the frequency of each metric at each level of CV health. The median or mean of each CV health metric was also estimated in the whole spectrum of CV health in all subgroups.
  
  
  RESULTS
  Only 1 adult participant met all 7 ideal CV health metrics; 25.01% of women and 26% of men had intermediate CV health; 74.8% of women and 74% of men exhibited poor CV health. Only 19.7% of women and 10.3% of men had 5 or more ideal CV health metrics. Nonsmoking was the most frequent ideal health behavior. A total of 89.6% of participants had 1 or 2 ideal CV health behaviors. Ideal smoking and fasting plasma glucose had the highest frequency of CV health factors among others.
  
  
  CONCLUSIONS
  The frequency of ideal CV health was extremely low in this cohort of adults. The frequency of intermediate CV health was also low, and it may be significantly lower in the general population.
authors.forename: Mariam Maleki
authors.initials: MM
authors.lastname: Moghaddam
authors.forename: Reza
authors.initials: R
authors.lastname: Mohebi
authors.forename: Firoozeh
authors.initials: F
authors.lastname: Hosseini
authors.forename: Mojtaba
authors.initials: M
authors.lastname: Lotfaliany
authors.forename: Fereidoun
authors.initials: F
authors.lastname: Azizi
authors.forename: Navid
authors.initials: N
authors.lastname: Saadat
authors.affiliation: Dr. Farzad Hadaegh, Research Institute for Endocrine Sciences,, Shahid Beheshti University of Medical Sciences,, PO Box 4763, Tehran 19395, Iran, T: +982122409301-5, F: +982122402463, fzhadaegh@endocrine.ac.ir.
authors.forename: Farzad
authors.initials: F
authors.lastname: Hadaegh
mesh_terms: D000328:Adult; D000572:American Heart Association; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D015444:Exercise; D005215:Fasting / Q000097:blood; D005260:Female; D015438:Health Behavior; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008877:Middle East / Q000453:epidemiology; D050177:Overweight / Q000453:epidemiology; D011446:Prospective Studies; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D013695:Temperance; D014481:United States
chemical_list: D001786:Blood Glucose; D002784:Cholesterol